NSE BSE
vanta bioscience limited stock

Vanta Bioscience Limited Share Price

- - (%)
Sector: -

540729

VANTABIO

img img img img
No Data Available

Vanta Bioscience Limited : Share Price Update


As of the latest trading session, Vanta Bioscience Limited share price is currently at 0, which is down by -73.50 from its previous closing. Today, the stock has fluctuated between 0.00 and 0.00. Over the past year, Vanta Bioscience Limited has achieved a return of 40.88 %. In the last month alone, the return has been 15.83 %.

Vanta Bioscience Limited Performance

Day Range

Low.00 High.00
75.20

52 Week Range

Low 37.00 High 101.64
75.20

Open Price

.00

Prev. Close

73.50

Volume (Shares)

6000.00

Total traded value

4.48

Upper Circuit

78.96

Lower Circuit

71.44

Note: The current prices & values are delayed, Login to your account for live updates.

Vanta Bioscience Limited Fundamentals


(Standalone)

Market Cap (Cr) 46.39
PE Ratio (TTM) 0.00
Book Value / Share 31.27
Beta 0.42
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -2.73

Vanta Bioscience Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2023 (Values in Cr)
Revenue 3.47
Operating Expense 6.80
Net Profit -2.73
Net Profit Margin (%) -78.67
Earnings Per Share (EPS) -4.32
EBITDA -0.17
Effective Tax Rate (%) -0.36
Particulars DEC 2022 (Values in Cr)
Revenue 1.71
Operating Expense 3.21
Net Profit -1.51
Net Profit Margin (%) -88.30
Earnings Per Share (EPS) -2.39
EBITDA 0.32
Effective Tax Rate (%) -0.67
Particulars MAR 2022 (Values in Cr)
Revenue 3.97
Operating Expense 4.29
Net Profit -0.17
Net Profit Margin (%) -4.28
Earnings Per Share (EPS) -0.27
EBITDA 1.57
Effective Tax Rate (%) 5.55
Particulars DEC 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 5.17
Operating Expense 10.01
Net Profit -4.24
Net Profit Margin (%) -82.01
Earnings Per Share (EPS) -6.71
EBITDA 0.14
Effective Tax Rate (%) -0.71
Particulars MAR 2022 (Values in Cr)
Revenue 9.35
Operating Expense 9.37
Net Profit 0.08
Net Profit Margin (%) 0.85
Earnings Per Share (EPS) 0.12
EBITDA 3.57
Effective Tax Rate (%) 42.85
Particulars MAR 2021 (Values in Cr)
Revenue 10.04
Operating Expense 9.46
Net Profit 0.47
Net Profit Margin (%) 4.68
Earnings Per Share (EPS) 0.75
EBITDA 3.92
Effective Tax Rate (%) 21.31
Particulars MAR 2020 (Values in Cr)
Revenue 14.11
Operating Expense 12.94
Net Profit 0.98
Net Profit Margin (%) 6.94
Earnings Per Share (EPS) 1.55
EBITDA 4.43
Effective Tax Rate (%) 24.03
Particulars MAR 2019 (Values in Cr)
Revenue 12.42
Operating Expense 11.55
Net Profit 0.69
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 1.17
EBITDA 3.49
Effective Tax Rate (%) 36.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.75
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.46
EBITDA Margin -27.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.03
ROE % 0.54
ROCE % 3.99
Total Debt to Total Equity 1.69
EBITDA Margin 40.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 37.89
ROE % 1.90
ROCE % 5.42
Total Debt to Total Equity 1.13
EBITDA Margin 39.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 37.18
ROE % 4.42
ROCE % 8.62
Total Debt to Total Equity 0.67
EBITDA Margin 31.68
Particulars MAR 2019 (Values in Cr)
Book Value / Share 35.25
ROE % 2.52
ROCE % 7.24
Total Debt to Total Equity 0.60
EBITDA Margin 26.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.06
EBITDA Margin 2.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.01
ROE % 0.33
ROCE % 5.24
Total Debt to Total Equity 0.79
EBITDA Margin 38.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 37.88
ROE % 1.99
ROCE % 6.75
Total Debt to Total Equity 0.66
EBITDA Margin 39.04
Particulars MAR 2020 (Values in Cr)
Book Value / Share 37.14
ROE % 4.29
ROCE % 8.87
Total Debt to Total Equity 0.60
EBITDA Margin 31.40
Particulars MAR 2019 (Values in Cr)
Book Value / Share 35.24
ROE % 2.83
ROCE % 8.06
Total Debt to Total Equity 0.63
EBITDA Margin 26.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 84.70
Total Liabilities 84.70
Total Equity 18.92
Share Outstanding 6312000
Price to Book Ratio 1.84
Return on Assets (%) -7.65
Return on Capital (%) -8.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 81.40
Total Liabilities 81.40
Total Equity 29.34
Share Outstanding 6312000
Price to Book Ratio 2.89
Return on Assets (%) 0.10
Return on Capital (%) 0.13
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 69.62
Total Liabilities 69.62
Total Equity 26.22
Share Outstanding 6312000
Price to Book Ratio 4.30
Return on Assets (%) 0.64
Return on Capital (%) 0.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.19
Total Assets 48.57
Total Liabilities 48.57
Total Equity 24.45
Share Outstanding 6312000
Price to Book Ratio 2.45
Return on Assets (%) 2.06
Return on Capital (%) 2.51
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 3.26
Total Assets 39.00
Total Liabilities 39.00
Total Equity 23.22
Share Outstanding 6312000
Price to Book Ratio 4.34
Return on Assets (%) 1.79
Return on Capital (%) 1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 51.63
Total Liabilities 51.63
Total Equity 19.74
Share Outstanding 6312000
Price to Book Ratio 1.84
Return on Assets (%) -8.20
Return on Capital (%) -9.31
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 50.39
Total Liabilities 50.39
Total Equity 23.98
Share Outstanding 6312000
Price to Book Ratio 2.89
Return on Assets (%) 0.15
Return on Capital (%) 0.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 46.24
Total Liabilities 46.24
Total Equity 23.91
Share Outstanding 6312000
Price to Book Ratio 4.30
Return on Assets (%) 1.01
Return on Capital (%) 1.14
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 41.58
Total Liabilities 41.58
Total Equity 23.44
Share Outstanding 6312000
Price to Book Ratio 2.45
Return on Assets (%) 2.35
Return on Capital (%) 2.74
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.28
Total Assets 38.00
Total Liabilities 38.00
Total Equity 22.24
Share Outstanding 6312000
Price to Book Ratio 4.34
Return on Assets (%) 1.82
Return on Capital (%) 2.02
Particulars MAR 2023 (Values in Cr)
Net Income -10.26
Cash from Operations -0.62
Cash from Investing -5.90
Cash from Financing 6.40
Net change in Cash -0.12
Free Cash Flow 28.06
Particulars MAR 2022 (Values in Cr)
Net Income 0.22
Cash from Operations 5.27
Cash from Investing -17.18
Cash from Financing 9.53
Net change in Cash -2.42
Free Cash Flow 5.61
Particulars MAR 2021 (Values in Cr)
Net Income 0.58
Cash from Operations 6.97
Cash from Investing -22.19
Cash from Financing 17.78
Net change in Cash 2.45
Free Cash Flow 7.82
Particulars MAR 2020 (Values in Cr)
Net Income 1.34
Cash from Operations 2.34
Cash from Investing -7.35
Cash from Financing 2.17
Net change in Cash -3.07
Free Cash Flow 2.68
Particulars MAR 2019 (Values in Cr)
Net Income 1.10
Cash from Operations -1.03
Cash from Investing -5.49
Cash from Financing 9.94
Net change in Cash 3.17
Free Cash Flow 1.43
Particulars MAR 2023 (Values in Cr)
Net Income -4.20
Cash from Operations 0.64
Cash from Investing -2.53
Cash from Financing 1.88
Net change in Cash 0.00
Free Cash Flow 3.17
Particulars MAR 2022 (Values in Cr)
Net Income 0.13
Cash from Operations 6.70
Cash from Investing -8.05
Cash from Financing 1.37
Net change in Cash 0.00
Free Cash Flow 14.75
Particulars MAR 2021 (Values in Cr)
Net Income 0.60
Cash from Operations 11.00
Cash from Investing -9.85
Cash from Financing -1.07
Net change in Cash -0.02
Free Cash Flow 11.88
Particulars MAR 2020 (Values in Cr)
Net Income 1.28
Cash from Operations 3.16
Cash from Investing -1.34
Cash from Financing -1.80
Net change in Cash -0.19
Free Cash Flow 3.51
Particulars MAR 2019 (Values in Cr)
Net Income 1.09
Cash from Operations -0.06
Cash from Investing -4.47
Cash from Financing 4.96
Net change in Cash 0.19
Free Cash Flow 2.41
Company Name Price P/E P/B Market Cap 52 Week Low/High
Vanta Bioscience Limited 73.50 0.00 2.64 46.39 37.00 / 101.64
Vanta Bioscience Ltd 29.00 0.00 -0.52 18.86 0.00 / 0.00
JAYKAY ENTERPRISES LTD. 135.05 91.87 4.40 789.47 41.80 / 169.00
MODI RUBBER LTD 98.00 15.73 0.37 245.39 59.01 / 119.00
THOMAS COOK (INDIA) LTD 211.20 38.40 6.53 9938.84 59.47 / 228.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
Vanta Bioscience Limited 73.50 0.00 2.35 46.39 37.00 / 101.64
Vanta Bioscience Ltd 29.00 0.00 -0.53 18.86 0.00 / 0.00
FGP LTD. 9.32 42.36 3.28 11.09 4.30 / 9.32
JAYKAY ENTERPRISES LTD. 135.05 61.11 4.90 789.47 41.80 / 169.00
MPIL CORPORATION LTD. 589.95 50.95 2.17 33.63 217.55 / 1264.05

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 71.30
  • 26 Days 73.70
  • 10 Days 69.00
  • 50 Days 67.50
  • 12 Days 68.10
  • 100 Days 62.20
  • 20 Days 69.10
  • 200 Days 92.70
72.81
PIVOT
First Resistance 74.19
Second Resistance 74.87
Third Resistance 76.25
First Support 72.13
Second Support 70.75
Third Support 70.07
RSI 59.22
MACD -5.63
Commodity Channel Index (CCI) 106.61
ADX 58.90
Williams % R -10.71

Over 1 Month

down

15.83

Over 3 Months

down

11.78

Over 6 Months

down

36.11

Over 1 Year

down

40.88

Over 3 Years

down

-22.88

Over 5 Years

down

-14.86

Vanta Bioscience Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Vanta Bioscience Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
30.64
Promoter Holdings
69.35
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Mohan Krishna Mulakala Shareholding of Promoter and Promoter Group 3485500.0 55.22
Dopesh Raja Mulakala Shareholding of Promoter and Promoter Group 458000.0 7.26
S Chandra Sekhar Rao Shareholding of Promoter and Promoter Group 122500.0 1.94
Soumya Simhadri Shareholding of Promoter and Promoter Group 90100.0 1.43
M Shikar Public Shareholding 81000.0 1.28
Shravan Chintapatla Shareholding of Promoter and Promoter Group 80100.0 1.27
Vimalchand A . Public Shareholding 69000.0 1.09
Emily Bosco Menezes Public Shareholding 64500.0 1.02
Bosco Armando Menezes Public Shareholding 63750.0 1.01
Mulakala Karishma Shareholding of Promoter and Promoter Group 50100.0 0.79
Vyasmurti Madhavrao Shingatgeri Shareholding of Promoter and Promoter Group 50000.0 0.79
Pradeep Chowdary Veeramachineni Shareholding of Promoter and Promoter Group 21500.0 0.34
M Sajan Kiran Shareholding of Promoter and Promoter Group 20100.0 0.32
Sujana Sheela Mulakala Shareholding of Promoter and Promoter Group 100.0 0.0

Vanta Bioscience Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Vanta Bioscience Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Vanta Bioscience Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vanta Bioscience Ltd?

Answer Field

The share price of Vanta Bioscience Ltd for NSE is ₹ 0.00 and for BSE is ₹ 0.

What is the Market Cap of Vanta Bioscience Ltd?

Answer Field

The market cap of Vanta Bioscience Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.00 Cr. as of now.

What is the 52 Week High and Low of Vanta Bioscience Ltd?

Answer Field

The 52 Week High and Low of Vanta Bioscience Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 101.64 and ₹ 37.00.

How to Buy Vanta Bioscience Ltd share?

Answer Field

You can trade in Vanta Bioscience Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vanta Bioscience Ltd?

Answer Field

The 1 year returns on the stock has been 40.88%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader